Abbott Receives U.S. FDA Clearance for New Cardiac Mapping System to Improve How Doctors Treat Abnormal Heart Rhythms
Retrieved on:
Wednesday, January 12, 2022
Patient, Technology, Stroke, LinkedIn, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Catheter, Arrhythmia, NYSE, Radio, Atrial fibrillation, Medical Center, Health, St Davids, E-GMS, Facebook, Nutritional muscular dystrophy, Heart failure, Catheter ablation, Heart, Method, Adviser, Saint David, Data collection, Food, Twitter, Software, Cell, Electrophysiology, Life, Physician, Medical imaging, Ventricular fibrillation
Designed with input from electrophysiologists from around the world, the system creates highly detailed three-dimensional maps of the heart to help physicians identify and then treat areas of the heart where abnormal rhythms originate.
Key Points:
- Designed with input from electrophysiologists from around the world, the system creates highly detailed three-dimensional maps of the heart to help physicians identify and then treat areas of the heart where abnormal rhythms originate.
- Millions of Americans are affected by abnormal heart rhythms caused by breakdowns in the electrical pathways of the heart.
- Increasingly, physicians are turning to cardiac ablation to treat cardiac arrhythmias because unlike medication the therapy treats the condition at the source by disrupting the area of the heart generating abnormal heart beats.
- These models provide a way to precisely identify areas that are causing problems, so physicians can better treat those abnormal heart rhythms, and preserve healthy tissue."